| VanEck Global Listed Private Credit (AUD Hedged) ETF (LEND) |
Financials |
$147 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$20.290 |
$18.790 |
fallen by
7.39%
|
|
| VanEck Australian Floating Rate ETF (FLOT) |
Financials |
$767 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$24.960 |
$24.970 |
risen by
0.04%
|
|
| VanEck 10+ Year Australian Government Bond ETF (XGOV) |
Financials |
$315 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$50.940 |
$52.310 |
risen by
2.69%
|
|
| VanEck Emerging Income Opportunities Active ETF (Managed Fund) (EBND) |
Financials |
$173 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$10.460 |
$10.580 |
risen by
1.15%
|
|
| VanEck Australian Corporate Bond Plus ETF (PLUS) |
Financials |
$379 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$16.990 |
$17.330 |
risen by
2%
|
|
| VanEck 1-3 Month US Treasury Bond ETF (TBIL) |
Financials |
$143 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$53.930 |
$51.190 |
fallen by
5.08%
|
|
| VanEck 5-10 Year Australian Government Bond ETF (5GOV) |
Financials |
$75 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$51.650 |
$53.350 |
risen by
3.29%
|
|
| VanEck Bentham Global Capital Securities Active ETF (Managed Fund) (GCAP) |
Financials |
$31 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$8.880 |
$8.860 |
fallen by
0.23%
|
|
| VanEck Australian Subordinated Debt ETF (SUBD) |
Financials |
$2,472 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$25.290 |
$25.110 |
fallen by
0.71%
|
|
| VanEck 1-5 Year Australian Government Bond ETF (1GOV) |
Financials |
$21 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$51.320 |
$52.320 |
risen by
1.95%
|
|
| Battery Age Minerals Ltd (BM8) ORDINARY FULLY PAID |
Materials |
$7 |
Trading Halt
|
31 Jan 2025 9:05AM |
$0.097 |
$0.055 |
fallen by
43.30%
|
|
BM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Battery Age Minerals Ltd requested a trading halt.
- The halt is pending an announcement regarding acquisition and capital raising.
- The trading halt will last until at least 4 February 2025.
- The company believes there is no reason for the trading halt to be denied.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Activex Limited (AIV) ORDINARY FULLY PAID |
Materials |
$2 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:05AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
AIV - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed a 2,416m reverse circulation drilling program at Mt Hogan Gold Mine.
- Notable gold intersections included 5m at 13 g/t Au and 1m at 50 g/t Au.
- Secured Doonkuna Rare Earth Elements tenement with significant REE potential.
- Financial position included $223,000 in cash and a $2.84 million loan facility.
- Andrew Bald resigned as Director effective November 28, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$108 |
Transformation Update Investor Presentation
|
31 Jan 2025 9:03AM |
$0.120 |
$0.099 |
fallen by
17.50%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$78 |
Completion of Recruitment of ACCENT Trial
|
31 Jan 2025 9:03AM |
$0.081 |
$0.200 |
risen by
146.91%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- The company has completed planned enrolment of the ACCENT Phase 2a clinical trial
- The ACCENT trial explores the activity of narmafotinib in advanced pancreatic cancer patients
- Full recruitment has been achieved 2 months ahead of schedule
- Top-line data is planned for release mid-Q3 2025
- Total of 10 confirmed partial responses has been recorded from the initial patient cohort
- Median duration on trial for the first cohort is currently 197 days, representing a 68% improvement over historical data
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$309 |
Update - Notification of buy-back - RG8
|
31 Jan 2025 9:02AM |
$2.130 |
$2.060 |
fallen by
3.29%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$20 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 9:02AM |
$0.040 |
$0.027 |
fallen by
32.50%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos recorded unaudited revenue of US$2.9 million, up 71% from Q2 FY24.
- The majority of revenue was from the Hologic fFN Development Agreement.
- Lumos generated US$2.3 million from diagnostic test and custom reader development services.
- The CLIA waiver study for FebriDx began, with the first patient tested on 19 December 2024.
- Lumos secured a reimbursement rate of US$41.38 per test for FebriDx.
- The company aims to expand market opportunities significantly with the CLIA waiver.
- Lumos ended the quarter with cash reserves of US$5.5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$446 |
Update - Notification of buy-back - VG1
|
31 Jan 2025 9:02AM |
$1.850 |
$1.795 |
fallen by
2.97%
|
|
| Peel Mining Limited (PEX) ORDINARY FULLY PAID |
Materials |
$43 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:01AM |
$0.120 |
$0.074 |
fallen by
38.33%
|
|
PEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 2 drilling at Wagga Tank intersects very high-grade mineralisation.
- Notable intercepts include 119m at 3.17% Cu and 1.49g/t Au.
- Strong oxide and supergene-style mineralisation confirmed at shallow depths.
- Potential for adding significant new resources within open-pittable depths.
- Fieldwork commenced on the Curnamona Project.
- $3.67 million cash at bank reported at the end of the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$108 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 9:01AM |
$0.120 |
$0.099 |
fallen by
17.50%
|
|
BET - Price-sensitive ASX Announcement
Full Release
Key Points
- Adjusted EBITDA loss reduced by 69% QonQ to $0.3 million.
- Operating cash flow improved by 43% QonQ to $1.3 million.
- Apollo Platform migration substantially complete, enhancing user experience.
- Annualized staff costs reduced by $5.1 million following restructuring.
- Closing cash balance as of December 31, 2024, is $20.8 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$177 |
Corporate Presentation
|
31 Jan 2025 9:01AM |
$0.275 |
$0.795 |
risen by
189.09%
|
|
| Jupiter Mines Limited. (JMS) ORDINARY FULLY PAID |
Materials |
$392 |
Q2 FY2025 Quarterly Activities Report
|
31 Jan 2025 9:00AM |
$0.145 |
$0.200 |
risen by
37.93%
|
|
JMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Tshipi recorded an EBITDA of A$26.9 million for Q2 FY2025.
- Production decreased by 39% to 745,167 tonnes compared to the previous quarter.
- Sales fell by 34% to 683,090 tonnes during the December 2024 quarter.
- Average CIF price for manganese decreased to US$3.72/dmtu.
- Cash reserves increased by 46% to A$141.4 million.
- The report highlights a strategic focus on future production despite current market challenges.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bayan Mining and Minerals Limited (BMM) ORDINARY FULLY PAID |
Materials |
$4 |
Pepita Gold Project Tenement Applications in Southern Brazil
|
31 Jan 2025 9:00AM |
$0.052 |
$0.035 |
fallen by
32.69%
|
|
BMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Bayan Mining has applied for a 13,406 hectare gold exploration permit in southern Brazil.
- The Pepita Project targets gold mineralization in the Santo Afonso Granite Suite.
- The area is strategically located near significant gold anomalies identified by government sampling.
- Initial exploration will focus on validating geochemical data and defining drill targets.
- Bayan has withdrawn from the Tango Lithium Project in Canada to concentrate on gold opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| nanollose Limited (NC6) ORDINARY FULLY PAID |
Health Care |
$20 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:59AM |
$0.016 |
$0.067 |
risen by
318.75%
|
|
NC6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Nanollose focused on product development and commercialization strategies.
- Raised $2.1 million through a capital raise including a placement and rights issue.
- Transitioning from R&D to commercialization of sustainable fibers.
- Advanced R&D projects in fabrics, fibers, agricultural products, and vegan leather.
- Positive feedback received from potential partners on Nullarbor and Nufolium fibers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$66 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:59AM |
$0.072 |
$0.230 |
risen by
219.44%
|
|
AR9 - Price-sensitive ASX Announcement
Full Release
Key Points
- archTIS reported a net positive cash flow of $2.6 million for the December 2024 quarter.
- Annual recurring revenue reached $4 million, a 12% increase from the previous year.
- Total revenue was $1.3 million, with $1 million coming from licensing.
- Gross margin increased to 78%, up 34 basis points compared to the prior corresponding period.
- The company secured significant contracts with Accenture, BAE Systems, and others.
- archTIS plans to acquire assets from Direktiv for $750,000 to enhance its technology offerings.
- Two key management appointments were made to strengthen the leadership team.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Many Peaks Minerals Limited (MPK) ORDINARY FULLY PAID |
Materials |
$69 |
Quarterly Activities Report & Appendix 5B
|
31 Jan 2025 8:59AM |
$0.240 |
$0.670 |
risen by
179.17%
|
|
MPK - Price-sensitive ASX Announcement
Full Release
Key Points
- 14,845m of drilling completed across the Ferké and Odienné gold projects.
- Identified multiple targets for extension of gold mineralization at the Ferké project.
- Peak assay result of 18.5g/t gold in auger located 3.8km south of Ouarigue target.
- Initial 1,000m diamond drilling campaign commenced at the Ferké gold project.
- Air core and RC drilling planned to commence in March quarter.
- Company has $5.9M cash at hand as at 31 December 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
